SITAXA DM (10/500) (Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg))
-15%

SITAXA DM (10/500) (Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg))

Original price was: ₹218.60.Current price is: ₹186.56.

Placeholder

Original price was: ₹218.60.Current price is: ₹186.56.

Add to cart
Buy Now
Category: Tag:

Sitaxa DM 10/100/500 Tablet ER is a medication formulated to aid in the management of blood glucose levels in individuals with type 2 diabetes mellitus. This pharmaceutical combines multiple active ingredients that work synergistically to enhance insulin sensitivity and facilitate glucose uptake, effectively reducing elevated blood sugar concentrations. It is essential to use this medication alongside lifestyle modifications, including a balanced diet, regular physical activity, and weight management, as recommended by a healthcare professional. The tablet can be ingested at any time, regardless of meals; however, it is advisable to maintain a consistent daily schedule for optimal efficacy. The healthcare provider will determine the appropriate dosage based on the patient’s individual health needs, and it is crucial not to discontinue use without prior consultation, as abrupt cessation may lead to a rise in blood glucose levels, potentially resulting in severe complications such as nephropathy and vision impairment. Staying hydrated is particularly important during treatment, as it can help mitigate the risk of dehydration, which can be exacerbated by certain side effects. Practicing good hygiene is also encouraged to prevent potential fungal infections that could arise. Prior to initiating treatment with Sitaxa DM, it is vital for patients to disclose any pre-existing kidney or liver conditions, urinary tract infections, or concurrent use of diuretics to their healthcare provider.

Reviews

There are no reviews yet.

Be the first to review “SITAXA DM (10/500) (Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg))”

Your email address will not be published. Required fields are marked *

Top